$54.00-5.82%
2026-10-06 closeCrispr Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $37M. 2024 operating profit was −$467M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy
Crispr Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $37M. 2024 operating profit was −$467M.